Market Trends of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Industry
The Arthritis Segment is Expected to Grow Faster and Dominate the Market Over the Forecast Period
- The increasing incidence of arthritis is predicted to accelerate the market for nonsteroidal anti-inflammatory drugs (NSAIDs), as they are commonly used in patients with chronic inflammatory arthritis. NSAIDs are effective in reducing inflammation and pain due to their ability to inhibit the biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme.
- The arthritis segment is expected to hold the major share over the forecast period due to the rising prevalence of arthritis among the global population and the increasing demand for effective pain management drugs. According to the Centers for Disease Control and Prevention (CDC) data updated in October 2021, doctor-diagnosed arthritis cases in the United States are expected to reach 78.4 million adults aged 18 and over by 2040. Arthritis prevalence also increases with age.
- Severe arthritis can limit physical activity, which is directly associated with obesity, cardiovascular disease, diabetes, and other functional limitations. The older population's increased vulnerability to arthritis due to age-related decline in bone density and weak joint ligaments is also expected to contribute to segment expansion.
- There are several drugs of the NSAIDs class on the market and many more are in the pipeline to meet the growing demand for arthritis pain management, thereby contributing to the growth of the studied segment. For instance, in January 2021, the United States Food and Drug Administration (US FDA) approved a generic version of Pfizer's Celebrex (celecoxib), an oral medication used to treat inflammation and pain caused by ankylosing spondylitis and other disorders. The generic drug is also indicated to treat osteoarthritis, rheumatoid arthritis, juvenile arthritis, acute pain, and primary dysmenorrhea (pain caused by menstruation). Thus, the above-mentioned factors are expected to drive the growth of the studied segment over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Dominate the Market and Expected to do Same Over the Forecast Period
- North America is poised to dominate the NSAIDs (non-steroidal anti-inflammatory drugs) market, holding a major share of the market throughout the forecast period. The increasing demand for effective drugs for pain relief and growing awareness among the North American population are key factors driving the growth of the market in this region.
- Chronic pain-causing disorders are prevalent among the North American population, which is expected to further drive the market. For instance, the American Migraine Foundation reported in February 2022 that nearly 39 million Americans live with migraines, and the United States Native American and Alaskan Native communities experience the highest prevalence of disabling headaches. Inflammatory diseases are also a significant burden, as per an NCBI article published in January 2021, where the age-adjusted prevalence of arthritis was 15.9% across all adults.
- Market players in North America are continuously focusing on the development of novel drugs to tackle these indications using NSAIDs. They are adopting various strategies to develop better drugs with reduced side effects, which is likely to drive the market in the region. For example, Dr. Reddy's laboratories re-launched over-the-counter Naproxen Sodium tablets of USP, 220 mg, in the United States market in August 2021. Naproxen Sodium is a non-steroidal anti-inflammatory drug used for pain relief and fever control.
- The high prevalence of arthritis in Canada is expected to contribute to the growing demand for NSAIDs for better pain management, thereby contributing to the growth of the market over the forecast period. According to the Statistics Canada data published in August 2022, the number of arthritis cases in Canada was 6,087,600 among people aged 12 years or over. This high frequency of the population suffering from arthritis is expected to contribute to the growth of the market.
- In view of these recent developments and other above-mentioned factors, the NSAIDs market is expected to get a boost in North America.
Get Analysis on Important Geographic Markets
Download PDF
